EGFR expression in primary squamous cell carcinoma of the thyroid

Laryngoscope

Volumn 119, Issue 1, 2009, Pages 89-90

  Long, Jennifer L ^a   Strocker, Ali M ^c   Wang, Marilene B ^a,b   Blackwell, Keith E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

EGFR; Squamous cell carcinoma; Thyroid

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SYMPTOM; THYROID CARCINOMA; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; THYROID TUMOR; THYROIDECTOMY;

CARCINOMA, SQUAMOUS CELL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 63249133571     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20062     Document Type: Article

References (8)

1. Booya F., Sebo TJ, Kasperbauer JL, Fatourechi V. Primary squamous cell carcinoma of the thyroid: report of ten cases. Thyroid 2006; 16:89-93.
2. Marti U., Ruchti C., Kämpf J., et al. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid 2001; 11: 137-145.
3. Wiseman SM, Masoudi H., Niblock P., et al. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann Surg Oncol 2007; 14:719-729.
4. Lee DH, Lee GK, Kong SY, et al. Epidermal growth factor receptor status in anaplastic thyroid carcinoma. J Clin Pathol 2007; 60:881-884.
5. Murakawa T., Tsuda H., Tanimoto T., Tanabe T., Kitahara S., Matsubara O. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach. Path Int 2005; 55:757-765.
6. Schiff BA, McMurphy AB, Jasser SA, et al. EGFR is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 2004; 10:8594-8602.
7. Ensinger C., Spizzo G., Moser P., et al. EGFR as a novel therapeutic target in anaplastic thyroid carcinoma. Ann NY Acad Sci 2004; 1030:69-77.
8. Kanamori A., Abe Y., Yajima Y., Manabe Y., Ito K. Epidermal growth factor receptors in plasma membranes of normal and diseased thyroid glands. J Clin Endocrinol Metab 1989; 68:899-903.